Literature DB >> 30663487

Genetic and Environmental Risk Factors for Cannabis Use: Preliminary Results for the Role of Parental Care Perception.

Maria Carla Gerra1, Matteo Manfredini1, Elena Cortese2, Maria Caterina Antonioni3, Claudio Leonardi2, Fernanda Magnelli4, Lorenzo Somaini4, Subramaniam Jayanthi5, Jean Lud Cadet5, Claudia Donnini1.   

Abstract

BACKGROUND: Vulnerability to cannabis use (CU) initiation and problematic use have been shown to be affected by both genetic and environmental factors, with still inconclusive and uncertain evidence.
OBJECTIVE: Aim of the present study was to investigate the possible interplay between gene polymorphisms and psychosocial conditions in CU susceptibility.
METHODS: Ninety-two cannabis users and ninety-three controls have been included in the study. Exclusion criteria were serious mental health disorders and severe somatic disorders, use of other drugs and alcohol abuse; control subjects were not screened to remove Reward Deficiency Syndrome (RDS) behaviors. A candidate gene association study was performed, including variants related to dopaminergic and endocannabinoids pathways. Adverse childhood experiences and quality of parental care have been retrospectively explored utilizing ACES (Adverse Children Experience Scale), CECA-q (Child Experience of Care and Abuse Questionnaire), PBI (Parental Bonding Instrument).
RESULTS: Our findings evidenced a significant association between rs1800497 Taq1A of ANKK1 gene and CU. Parental care was found to be protective factor, with emotional and physical neglect specifically influencing CU. Gender also played a role in CU, with males smoking more than females. However, when tested together genotypes and psychosocial variables, the significance of observed genetic differences disappeared.
CONCLUSIONS: Our results confirm a significant role of Taq1A polymorphism in CU vulnerability. A primary role of environmental factors in mediating genetic risk has been highlighted: parental care could be considered the main target to design early prevention programs and strategies.

Entities:  

Keywords:  Cannabis; adverse childhood experiences; biomarkers; genetics; parental care; risk factors

Mesh:

Substances:

Year:  2019        PMID: 30663487      PMCID: PMC7643561          DOI: 10.1080/10826084.2018.1531430

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  53 in total

1.  Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood.

Authors:  Kenneth S Kendler; Eric Schmitt; Steven H Aggen; Carol A Prescott
Journal:  Arch Gen Psychiatry       Date:  2008-06

2.  Allelic association of human dopamine D2 receptor gene in alcoholism.

Authors:  K Blum; E P Noble; P J Sheridan; A Montgomery; T Ritchie; P Jagadeeswaran; H Nogami; A H Briggs; J B Cohn
Journal:  JAMA       Date:  1990-04-18       Impact factor: 56.272

3.  A genome-wide association study of DSM-IV cannabis dependence.

Authors:  Arpana Agrawal; Michael T Lynskey; Anthony Hinrichs; Richard Grucza; Scott F Saccone; Robert Krueger; Rosalind Neuman; William Howells; Sherri Fisher; Louis Fox; Robert Cloninger; Danielle M Dick; Kimberly F Doheny; Howard J Edenberg; Alison M Goate; Victor Hesselbrock; Eric Johnson; John Kramer; Samuel Kuperman; John I Nurnberger; Elizabeth Pugh; Marc Schuckit; Jay Tischfield; John P Rice; Kathleen K Bucholz; Laura J Bierut
Journal:  Addict Biol       Date:  2010-11-04       Impact factor: 4.280

4.  Genetic and Environmental Factors Associated with Cannabis Involvement.

Authors:  Ryan Bogdan; Jonathan Ma Winstone; Arpana Agrawal
Journal:  Curr Addict Rep       Date:  2016-04-12

5.  Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? Results from the national epidemiological survey on alcohol and related conditions.

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Drug Alcohol Depend       Date:  2006-11-03       Impact factor: 4.492

6.  The dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviors.

Authors:  Guang Guo; Tianji Cai; Rui Guo; Hongyu Wang; Kathleen Mullan Harris
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

7.  Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.

Authors:  Richard Sherva; Qian Wang; Henry Kranzler; Hongyu Zhao; Ryan Koesterer; Aryeh Herman; Lindsay A Farrer; Joel Gelernter
Journal:  JAMA Psychiatry       Date:  2016-05-01       Impact factor: 21.596

8.  Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

Authors:  Joseph F Cheer; Kate M Wassum; Michael L A V Heien; Paul E M Phillips; R Mark Wightman
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

9.  The ANKK1 kinase gene and psychiatric disorders.

Authors:  Guillermo Ponce; Rocío Pérez-González; María Aragüés; Tomás Palomo; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Janet Hoenicka
Journal:  Neurotox Res       Date:  2009-04-07       Impact factor: 3.911

10.  Perceptions of parental bonding in freebase cocaine users versus non-illicit drug users.

Authors:  Marcia Pettenon; Felix Henrique Paim Kessler; Luciano S P Guimarães; Rosemeri Siqueira Pedroso; Simone Hauck; Flavio Pechansky
Journal:  Indian J Med Res       Date:  2014-06       Impact factor: 2.375

View more
  7 in total

1.  Pharmacogenetics of Addiction Therapy.

Authors:  David P Graham; Mark J Harding; David A Nielsen
Journal:  Methods Mol Biol       Date:  2022

2.  Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies.

Authors:  M Taylor; J Cousijn; F Filbey
Journal:  Curr Addict Rep       Date:  2019-10-24

3.  3-Year Follow-up of Lower Risk Cannabis Use Patterns: Evidence from a Longitudinal Survey.

Authors:  Tongtong Chen; Ahmed N Hassan; Bernard Le Foll
Journal:  Can J Psychiatry       Date:  2021-03-04       Impact factor: 5.321

4.  In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.

Authors:  Kenneth Blum; David Baron; Lisa Lott; Jessica V Ponce; David Siwicki; Brent Boyett; Bruce Steinberg; Edward J Modestino; Lyle Fried; Mary Hauser; Thomas Simpatico; Bill W Downs; Thomas McLaughlin; Raju Hajela; Rajendra D Badgaiyan
Journal:  Curr Psychopharmacol       Date:  2020

Review 5.  Understanding the genetics and neurobiological pathways behind addiction (Review).

Authors:  Alexandra Popescu; Maria Marian; Ana Miruna Drăgoi; Radu-Virgil Costea
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

6.  Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.

Authors:  Ashim Gupta; Abdalla Bowirrat; Luis Llanos Gomez; David Baron; Igor Elman; John Giordano; Rehan Jalali; Rajendra D Badgaiyan; Edward J Modestino; Mark S Gold; Eric R Braverman; Anish Bajaj; Kenneth Blum
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

7.  Neurogenetic and Epigenetic Aspects of Cannabinoids.

Authors:  Catherine A Dennen; Kenneth Blum; Abdalla Bowirrat; Jag Khalsa; Panayotis K Thanos; David Baron; Rajendra D Badgaiyan; Ashim Gupta; Eric R Braverman; Mark S Gold
Journal:  Epigenomes       Date:  2022-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.